Dr. med. Ulrich Baumann develops the concept of measuring the venous pressure non-invasively. Initial feasibility tests show very promizing results.

VeinPress Ltd. is founded in Münsingen, Switzerland.

First scientific results are published by various research groups in renowned scientific journals, including contributions from university hospitals in Basel, Zurich, and Bern.

The VeinPress prototype is further developed in collaboration with ETH Zurich and the University Hospital of Basel.

VeinPress wins the prestigious Swiss Medtech Award together with its scientific partners ETH Zurich and the University Hospital Basel.

The Compremium method takes flight - NASA starts first tests on the ground in their research labs at Houston, TX and in Cologne, Germany. The tests were followed by intensive testing in parabolic flights with NASA crew members out of Bordeaux, France.

PD Dr. med. Richard M. Sellei, Chief Physician of the Department of Orthopaedic and Trauma Surgery at Sana Klinikum Offenbach, publishes first study on the method of measuring compartment elasticity using pressure related ultrasound to identify patients with potential compartment syndrome.

NASA initiates a series of scientific tests in space on the International Space Station. Other medical applications are explored by various independent research groups.

Three studies on the use of the VeinPress method on elevated compartment pressure of the leg are published. NASA publishes the study on the Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight.

Compremium AG is founded in Muri b. Bern, Switzerland entirely integrating VeinPress

Scientific collaboration starts with Maxima Medisch Center and Dr. med. Marc Scheltinga in Veldhoven, Netherlands.

Andrea Rytz, CEO of the Schulthess Klinik in Zurich initiates the scientific collaboration with Compremium.

The first Compremium Compressibility Forum takes place at the PostFinance Arena in Bern.

FDA clearance study conducted at the University Hospital, Inselspital in Bern by Dr. med. Beat Lehmann, Deputy Chief Physician and Head of the Emergency Department and his team.

Clinical partnership established with Charité - Universitätsmedizin Berlin and Prof. Dr. med. Ulrich Stöckle, Executive Director, Center for Musculoskeletal Surgery

Compremium receives FDA clearance for the CPMX-1 System.

CPMX-1 is now MIL-STD 810H compliant and ready for duty! MIL-STD-810H is a military standard developed by the U.S. Department of Defense to test the resistance of equipment to environmental conditions.

Compremium exhibits at SOMA 2024 in Raleigh, NC, showcasing the CPMX-1 Combat System

Scientific collaboration starts with Inselspital Bern and Prof. Dr. med. Annalisa Berzigotti, Clinic Director and Chief Physician Hepatology, University Clinic for Visceral Surgery and Medicine

Compremium AG is ISO 13485 certified! This milestone underscores our commitment to top-tier quality in designing and developing active medical devices for our non-invasive measurement solutions.

Compremium wins the Alliance for Pediatric Device Innovation (APDI) award, a federally funded consortium led by Children's National Hospital. This years focus was on improving care for children with heart conditions.

Compremium exhibits at Global Health in Riyadh, showcasing Swiss-engineered precision in healthcare.

Children’s National Hospital and Compremium initiate partnership to co-develop and commercialize innovative medical technologies designed specifically for pediatric patients.

Kickoff of collaboration with Universitätsklinikum Freiburg, Germany.

Fracture treatment starts with soft tissue management. Compremium present its solution at the AO Dreiländertagung in Lugano.